Cambridge, MA · Founded 2021 · Privately Held (backing)
Developer of he world's first cell-based design, optimisation and manufacturing platform to make pure, non-immunogenic, and highly functional messenger RNA (mRNA) to unlock the next generation of… Sensible Biotechnologies is based in Cambridge, MA and was founded in 2021. It has raised $13.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$13.8M
Last round
—
Cap table — not yet on record
Sensible Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sensible Biotechnologies with a free account
·The complete investor list: 25 names
·Watch Sensible Biotechnologies: the Monday email on marks, rounds and moves
